DE2833986C2 - - Google Patents

Info

Publication number
DE2833986C2
DE2833986C2 DE2833986A DE2833986A DE2833986C2 DE 2833986 C2 DE2833986 C2 DE 2833986C2 DE 2833986 A DE2833986 A DE 2833986A DE 2833986 A DE2833986 A DE 2833986A DE 2833986 C2 DE2833986 C2 DE 2833986C2
Authority
DE
Germany
Prior art keywords
formula
compound
general formula
compounds
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2833986A
Other languages
German (de)
English (en)
Other versions
DE2833986A1 (de
Inventor
Elmar Dr.Rer.Nat. 6148 Heppenheim De Bosies
Herbert Dr.Phil. 6800 Mannheim De Berger
Wolfgang Dr.Rer.Nat. 6805 Heddesheim De Kampe
Uwe Dr.Rer.Nat. 6800 Mannheim De Bicker
Alfred Dr.Phil.Nat. 6942 Moerlenbach De Grafe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE19782858177 priority Critical patent/DE2858177C2/de
Priority to DE19782833986 priority patent/DE2833986A1/de
Priority to CA000332281A priority patent/CA1142530A/en
Priority to KR7902440A priority patent/KR860000320B1/ko
Priority to US06/059,863 priority patent/US4321194A/en
Priority to AU49308/79A priority patent/AU524572B2/en
Priority to AR277498A priority patent/AR228945A1/es
Priority to CS795237A priority patent/CS227301B2/cs
Priority to LU81563A priority patent/LU81563A1/de
Priority to IT24769/79A priority patent/IT1123503B/it
Priority to DK320379A priority patent/DK156431C/da
Priority to NLAANVRAGE7905855,A priority patent/NL187239C/xx
Priority to PH22826A priority patent/PH19007A/en
Priority to GR59726A priority patent/GR74424B/el
Priority to SE7906461A priority patent/SE445552B/sv
Priority to IL57939A priority patent/IL57939A/xx
Priority to NZ191169A priority patent/NZ191169A/xx
Priority to CH707079A priority patent/CH645540A5/de
Priority to DD79214711A priority patent/DD145267A5/de
Priority to PT70009A priority patent/PT70009A/pt
Priority to FI792393A priority patent/FI70570C/fi
Priority to BE0/196560A priority patent/BE878020A/fr
Priority to SU792791952A priority patent/SU1145927A3/ru
Priority to GB08215159A priority patent/GB2106896B/en
Priority to FR7919830A priority patent/FR2432317A1/fr
Priority to HU79BO1800A priority patent/HU184610B/hu
Priority to PL1979217527A priority patent/PL126531B1/pl
Priority to GB7926975A priority patent/GB2026863B/en
Priority to YU1881/79A priority patent/YU41169B/xx
Priority to ZA00793966A priority patent/ZA793966B/xx
Priority to AT0531479A priority patent/AT379382B/de
Priority to NO792545A priority patent/NO152413C/no
Priority to OA56865A priority patent/OA06310A/xx
Priority to JP9878079A priority patent/JPS5522694A/ja
Priority to ES483116A priority patent/ES483116A1/es
Priority to EG473/79A priority patent/EG14369A/xx
Priority to IE1478/79A priority patent/IE48462B1/en
Priority to FR8003132A priority patent/FR2445316A1/fr
Publication of DE2833986A1 publication Critical patent/DE2833986A1/de
Priority to US06/268,964 priority patent/US4409236A/en
Priority to US06/334,614 priority patent/US4410532A/en
Priority to AT140684A priority patent/AT386195B/de
Priority to SG857/84A priority patent/SG85784G/en
Priority to KE3493A priority patent/KE3493A/xx
Priority to HK132/85A priority patent/HK13285A/xx
Priority to MY45/86A priority patent/MY8600045A/xx
Priority to JP62083962A priority patent/JPS63258415A/ja
Application granted granted Critical
Publication of DE2833986C2 publication Critical patent/DE2833986C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE19782833986 1978-08-03 1978-08-03 Immunstimulierende n-substituierte aziridin-2-carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese substanzen enthalten Granted DE2833986A1 (de)

Priority Applications (46)

Application Number Priority Date Filing Date Title
DE19782858177 DE2858177C2 (de) 1978-08-03 1978-08-03 Arzneimittel enthaltend N-substituierte 2-Cyanaziridine
DE19782833986 DE2833986A1 (de) 1978-08-03 1978-08-03 Immunstimulierende n-substituierte aziridin-2-carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese substanzen enthalten
CA000332281A CA1142530A (en) 1978-08-03 1979-07-20 Immunestimulating n-substituted aziridine- 2-carboxylic acid derivatives
KR7902440A KR860000320B1 (ko) 1978-08-03 1979-07-20 N-치환 아지리딘-2-카르복실산 유도체의 제조방법
US06/059,863 US4321194A (en) 1978-08-03 1979-07-23 N-Substituted aziridine-2-carboxylic acid derivatives for immuno stimulation
AU49308/79A AU524572B2 (en) 1978-08-03 1979-07-27 Immune stimulating n-substituted aziridine-2-carboxylic acid derivatives
AR277498A AR228945A1 (es) 1978-08-03 1979-07-27 Procedimiento para preparar derivados n-sustituidos del acido aziridina-2-carboxilico
CS795237A CS227301B2 (en) 1978-08-03 1979-07-27 Method of preparing n-substituted aziridine-2-carboxylic acid derivatives
LU81563A LU81563A1 (de) 1978-08-03 1979-07-30 Immunstimulierende n-substituierte aziridin-2-carbonsaeure-derivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese substanzen enthalten
IT24769/79A IT1123503B (it) 1978-08-03 1979-07-30 Derivati di acidi aziridin-2-carbossilici n-sostituiti con attivita'immunostimolante,processi per la loro preparazione e farmaci contenenti tali sostanze
DK320379A DK156431C (da) 1978-08-03 1979-07-30 Analogifremgangsmaade til fremstilling af n-substituerede 2-cyanaziridiner
NLAANVRAGE7905855,A NL187239C (nl) 1978-08-03 1979-07-30 N-gesubstitueerd 2-cyaanaziridinederivaat, werkwijze voor het bereiden daarvan en farmaceutisch preparaat dat een dergelijk preparaat bevat.
PH22826A PH19007A (en) 1978-08-03 1979-07-30 N-substituted aziridine-2-carboxylic acid derivatives and their immuno-stimulation compositions and methods
GR59726A GR74424B (US07923587-20110412-C00001.png) 1978-08-03 1979-07-30
SE7906461A SE445552B (sv) 1978-08-03 1979-07-30 N-substituerade 2-cyanaziridiner forfarande for framstellning derav samt komposition derav
IL57939A IL57939A (en) 1978-08-03 1979-07-31 Pharmaceutical compositions containing n-substituted aziridine-2-carboxylic acid derivatives,some such novel compounds and processes for the preparation of said n-substituted aziridine-2-carboxylic acid derivatives
NZ191169A NZ191169A (en) 1978-08-03 1979-07-31 N-substituted aziridine-2-carboxylic acid derivatives and pharmaceutical compositions
CH707079A CH645540A5 (de) 1978-08-03 1979-07-31 Arzneimittel mit immunstimulierender wirkung, darin enthaltene n-substiuierte aziridin-2-carbonsaeurederivate und verfahren zu ihrer herstellung.
DD79214711A DD145267A5 (de) 1978-08-03 1979-07-31 Verfahren zur herstellung n-substituierter aziridin-2-carbonsaeurederivate
PT70009A PT70009A (de) 1978-08-03 1979-07-31 Immunstimulierende n-substituierte aziridin-2-carbonsaurederivate verfahren zu ihrer herstellung sowie arzneimittel die diese substanzen enthalten
FI792393A FI70570C (fi) 1978-08-03 1979-07-31 Foerfarande foer framstaellning av immunitetstimulerande n-substituerade aziridin-2-cyanderivat
BE0/196560A BE878020A (fr) 1978-08-03 1979-08-01 Derives n-substitues de l'acide aziridine-2-carboxylique immunostimulateurs, procedes de preparation et compositions pharmaceutiques les contenant
SU792791952A SU1145927A3 (ru) 1978-08-03 1979-08-01 Способ получени @ -замещенных производных 2-цианазиридинов
GB08215159A GB2106896B (en) 1978-08-03 1979-08-02 N-substituted aziridine-2-carboxylic acid derivatives
FR7919830A FR2432317A1 (fr) 1978-08-03 1979-08-02 Nouveaux derives n-substitues de l'acide aziridinyl 2-carboxylique presentant une activite immunostimulante, leur procede de preparation et leurs applications therapeutiques
HU79BO1800A HU184610B (en) 1978-08-03 1979-08-02 Process for producing immunostimulating n-substituted-aziridine-2-carboxylic acid derivatives
PL1979217527A PL126531B1 (en) 1978-08-03 1979-08-02 Method for producing new n-substituted derivatives of aziridine-2-carboxylic acid
GB7926975A GB2026863B (en) 1978-08-03 1979-08-02 Pharmaceutical compositions containing aziridine derivatives
YU1881/79A YU41169B (en) 1978-08-03 1979-08-02 Process for preparing n-substituted derivatives of aziride-2-carboxylic acids
ZA00793966A ZA793966B (en) 1978-08-03 1979-08-02 N-substituted aziridine-2-carboxylic acid derivatives,processes for their preparation,and pharmaceutical compositions thereof
AT0531479A AT379382B (de) 1978-08-03 1979-08-02 Verfahren zur herstellung von neuen n-substituierten aziridin-2-carbonsaeurederivaten
NO792545A NO152413C (no) 1978-08-03 1979-08-02 Analogifremgangsmaate ved fremstilling av immunstimulerende n-substituerte aziridin-2-cyanderivater
OA56865A OA06310A (fr) 1978-08-03 1979-08-03 Nouveaux dérivés N-substitués de l'acide aziridinyl-2-carboxylique et leur procédé de préparation.
JP9878079A JPS5522694A (en) 1978-08-03 1979-08-03 N substituted aziridinn22carboxylic acid derivative*its manufacture and immunity stimulant drug containing it
ES483116A ES483116A1 (es) 1978-08-03 1979-08-03 Procedimiento para la preparacion de derivados de acidos aziridin-2-carboxilicos substituidos en n, inmunoestimulan- tes
EG473/79A EG14369A (en) 1978-08-03 1979-08-04 Process for the preparation of an immune stimulating n-substituted oziridine-2-carboxylic acid derivatives
IE1478/79A IE48462B1 (en) 1978-08-03 1979-08-08 N-substituted aziridine-2-carboxylic acid derivatives and process for the preparation thereof
FR8003132A FR2445316A1 (fr) 1978-08-03 1980-02-13 Nouveaux derives n-substitues de l'acide aziridinyl 2-carboxylique presentant une activite immunostimulante, leur procede de preparation et leurs applications therapeutiques
US06/268,964 US4409236A (en) 1978-08-03 1981-06-01 N-Substituted aziridine-2-carboxylic acid derivatives and immuno-stimulation composition and method
US06/334,614 US4410532A (en) 1978-08-03 1981-12-28 N-Substituted aziridine-2-carboxylic acid derivatives and their immuno-stimulation compositions and methods
AT140684A AT386195B (de) 1978-08-03 1984-04-27 Verfahren zur herstellung von neuen n-substituierten aziridin-2-carbonsaeurederivaten und ihren salzen
SG857/84A SG85784G (en) 1978-08-03 1984-11-29 Pharmaceutical compositions containing immunestimulating n-substituted aziridine-2-carboxylic acid derivatives
KE3493A KE3493A (en) 1978-08-03 1985-01-04 Pharmaceutical compositions containing immunestimulat n-substituted aziridine-2-carboxylic acid derivatives
HK132/85A HK13285A (en) 1978-08-03 1985-02-19 Pharmaceutical compositions containing immunestimulating n-substituted aziridine-2-carboxylic acid derivatives
MY45/86A MY8600045A (en) 1978-08-03 1986-12-30 Pharmaceutical compositions containing immunestimulating n-substituted aziridine-2-carboxylic acid derivatives
JP62083962A JPS63258415A (ja) 1978-08-03 1987-04-07 Ｎ−置換２−シアンアジリジンを含有する免疫刺戟性薬剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782833986 DE2833986A1 (de) 1978-08-03 1978-08-03 Immunstimulierende n-substituierte aziridin-2-carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese substanzen enthalten

Publications (2)

Publication Number Publication Date
DE2833986A1 DE2833986A1 (de) 1980-02-21
DE2833986C2 true DE2833986C2 (US07923587-20110412-C00001.png) 1988-04-07

Family

ID=6046078

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782833986 Granted DE2833986A1 (de) 1978-08-03 1978-08-03 Immunstimulierende n-substituierte aziridin-2-carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese substanzen enthalten

Country Status (39)

Country Link
US (3) US4321194A (US07923587-20110412-C00001.png)
JP (2) JPS5522694A (US07923587-20110412-C00001.png)
KR (1) KR860000320B1 (US07923587-20110412-C00001.png)
AR (1) AR228945A1 (US07923587-20110412-C00001.png)
AT (1) AT379382B (US07923587-20110412-C00001.png)
AU (1) AU524572B2 (US07923587-20110412-C00001.png)
BE (1) BE878020A (US07923587-20110412-C00001.png)
CA (1) CA1142530A (US07923587-20110412-C00001.png)
CH (1) CH645540A5 (US07923587-20110412-C00001.png)
CS (1) CS227301B2 (US07923587-20110412-C00001.png)
DD (1) DD145267A5 (US07923587-20110412-C00001.png)
DE (1) DE2833986A1 (US07923587-20110412-C00001.png)
DK (1) DK156431C (US07923587-20110412-C00001.png)
EG (1) EG14369A (US07923587-20110412-C00001.png)
ES (1) ES483116A1 (US07923587-20110412-C00001.png)
FI (1) FI70570C (US07923587-20110412-C00001.png)
FR (2) FR2432317A1 (US07923587-20110412-C00001.png)
GB (2) GB2106896B (US07923587-20110412-C00001.png)
GR (1) GR74424B (US07923587-20110412-C00001.png)
HK (1) HK13285A (US07923587-20110412-C00001.png)
HU (1) HU184610B (US07923587-20110412-C00001.png)
IE (1) IE48462B1 (US07923587-20110412-C00001.png)
IL (1) IL57939A (US07923587-20110412-C00001.png)
IT (1) IT1123503B (US07923587-20110412-C00001.png)
KE (1) KE3493A (US07923587-20110412-C00001.png)
LU (1) LU81563A1 (US07923587-20110412-C00001.png)
MY (1) MY8600045A (US07923587-20110412-C00001.png)
NL (1) NL187239C (US07923587-20110412-C00001.png)
NO (1) NO152413C (US07923587-20110412-C00001.png)
NZ (1) NZ191169A (US07923587-20110412-C00001.png)
OA (1) OA06310A (US07923587-20110412-C00001.png)
PH (1) PH19007A (US07923587-20110412-C00001.png)
PL (1) PL126531B1 (US07923587-20110412-C00001.png)
PT (1) PT70009A (US07923587-20110412-C00001.png)
SE (1) SE445552B (US07923587-20110412-C00001.png)
SG (1) SG85784G (US07923587-20110412-C00001.png)
SU (1) SU1145927A3 (US07923587-20110412-C00001.png)
YU (1) YU41169B (US07923587-20110412-C00001.png)
ZA (1) ZA793966B (US07923587-20110412-C00001.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3446713A1 (de) * 1984-12-21 1986-06-26 Boehringer Mannheim Gmbh, 6800 Mannheim N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel
JPS6287512A (ja) * 1985-10-11 1987-04-22 ベ−リンガ−・マンハイム・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 選択的免疫抑制剤
US4925835A (en) * 1986-05-01 1990-05-15 Sloan-Kettering Institute For Cancer Research Aziridinyl putrescine containing compositions and their uses in treating prostate cancer
KR19980083844A (ko) * 1997-05-19 1998-12-05 이웅열 새로운 아지리딘 유도체 및 그 제조방법
FR2776292B1 (fr) * 1998-03-20 2004-09-10 Oncopharm Cephalotaxanes porteurs de chaine laterale et leur procede de synthese
KR20010000195A (ko) * 2000-08-10 2001-01-05 하현준 (2ｒ)- 및 (2ｓ)-아지리딘-2-카르복실산 에스테르 및(2ｒ)- 및 (2ｓ)-2-히드록시메틸 아지리딘 제조 방법
US20030129222A1 (en) * 2000-11-21 2003-07-10 Gabriel Lopez-Berestein Liposomal imexon
AU2002216672A1 (en) * 2000-11-21 2002-06-03 Arizona Board Of Regents On Behalf Of The University Of Arizona Composition comprising an imexon or derivatives thereof and lipids
US6982263B2 (en) * 2001-06-08 2006-01-03 Boehringer Ingelheim Pharmaceuticals, Inc. Nitriles useful as reversible inhibitors of cysteine proteases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470223A1 (de) * 1962-09-05 1969-12-04 Siegfried Ag Verfahren zur Herstellung neuer stickstoffhaltiger Heterocyclen
DE2528460A1 (de) * 1975-06-26 1977-01-13 Boehringer Mannheim Gmbh Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE2530960A1 (de) 1975-07-11 1977-01-27 Huels Chemische Werke Ag 2-(n-substituierte)-aziridinyl-delta hoch 2 -oxazoline und verfahren zu ihrer herstellung
DE2538672A1 (de) * 1975-08-30 1977-03-10 Boehringer Mannheim Gmbh Verwendung von derivaten der propionsaeure
DE2656240C2 (de) * 1976-12-11 1983-11-03 Boehringer Mannheim Gmbh, 6800 Mannheim Neue Aziridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Mittel
CA1092606A (en) * 1976-10-05 1980-12-30 Herbert Berger 1-(n-acylcarbamoyl)-2-cyano-aziridines and the preparation thereof
GB1550065A (en) * 1976-10-29 1979-08-08 Inst Organicheskogo Sinteza Ak Pharmaceutical composition processing antitumour activity
AR218645A1 (es) * 1976-12-11 1980-06-30 Boehringer Mannheim Gmbh Procedimiento para preparar derivados de esteres del acido 1-aziridina-carboxilico

Also Published As

Publication number Publication date
OA06310A (fr) 1981-06-30
LU81563A1 (de) 1980-08-08
AU524572B2 (en) 1982-09-23
NZ191169A (en) 1981-01-23
CA1142530A (en) 1983-03-08
PH19007A (en) 1985-12-03
FR2445316A1 (fr) 1980-07-25
GR74424B (US07923587-20110412-C00001.png) 1984-06-28
GB2026863B (en) 1983-03-30
CH645540A5 (de) 1984-10-15
NO152413B (no) 1985-06-17
YU41169B (en) 1986-12-31
HU184610B (en) 1984-09-28
KR860000320B1 (ko) 1986-04-09
FI70570C (fi) 1986-09-24
DK156431B (da) 1989-08-21
US4321194A (en) 1982-03-23
NL7905855A (nl) 1980-02-05
AR228945A1 (es) 1983-05-13
YU188179A (en) 1983-06-30
KE3493A (en) 1985-02-01
PL217527A1 (US07923587-20110412-C00001.png) 1980-07-01
NL187239C (nl) 1991-07-16
MY8600045A (en) 1986-12-31
ATA531479A (de) 1985-05-15
JPS63258415A (ja) 1988-10-25
JPS6243991B2 (US07923587-20110412-C00001.png) 1987-09-17
IL57939A0 (en) 1979-11-30
FI70570B (fi) 1986-06-06
IT1123503B (it) 1986-04-30
HK13285A (en) 1985-03-01
GB2106896A (en) 1983-04-20
AU4930879A (en) 1980-02-07
FR2432317A1 (fr) 1980-02-29
ES483116A1 (es) 1980-04-16
KR830000902A (ko) 1983-04-28
JPS5522694A (en) 1980-02-18
PL126531B1 (en) 1983-08-31
US4409236A (en) 1983-10-11
JPH0257523B2 (US07923587-20110412-C00001.png) 1990-12-05
GB2106896B (en) 1983-08-17
DE2833986A1 (de) 1980-02-21
IL57939A (en) 1985-02-28
BE878020A (fr) 1980-02-01
DD145267A5 (de) 1980-12-03
IE791478L (en) 1980-02-03
FI792393A (fi) 1980-02-04
FR2432317B1 (US07923587-20110412-C00001.png) 1983-03-18
SE7906461L (sv) 1980-02-04
CS227301B2 (en) 1984-04-16
NO792545L (no) 1980-02-05
DK320379A (da) 1980-02-04
NO152413C (no) 1985-09-25
DK156431C (da) 1990-01-22
SE445552B (sv) 1986-06-30
PT70009A (de) 1979-08-01
AT379382B (de) 1985-12-27
FR2445316B1 (US07923587-20110412-C00001.png) 1983-07-29
ZA793966B (en) 1980-08-27
SU1145927A3 (ru) 1985-03-15
SG85784G (en) 1985-06-07
IE48462B1 (en) 1985-01-23
IT7924769A0 (it) 1979-07-30
GB2026863A (en) 1980-02-13
EG14369A (en) 1983-12-31
US4410532A (en) 1983-10-18

Similar Documents

Publication Publication Date Title
DE2915254C2 (US07923587-20110412-C00001.png)
EP0022958A1 (de) Harnstoffderivate zur Verwendung bei der Behandlung von Fettstoffwechselstörungen
EP0014976B1 (de) N-substituierte 2-Cyanaziridine, Verfahren zu deren Herstellung sowie diese Substanzen enthaltende Arzneimittel, entsprechend substituierte Aziridin-2-carbonsäureamide und deren Herstellung
CH621800A5 (US07923587-20110412-C00001.png)
DE19621038A1 (de) Aminoguanidine, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
CH630604A5 (de) Verfahren zur herstellung von neuen acetylenderivaten von aminosaeuren.
DE2833986C2 (US07923587-20110412-C00001.png)
DE2856753A1 (de) N-substituierte omega -aminoalkanoyl- omega -aminoalkansaeuren, ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
DE69903040T2 (de) Piperazinderivate zur replikationshemmung von menschlichem immundefizienz virus
AT391320B (de) Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel
DD291551A5 (de) Verfahren zur herstellung von substituierten hydroxamsaeurederivaten
CH653340A5 (de) (e)-5-(2-bromvinyl)-uridine und verfahren zu ihrer herstellung.
AT390437B (de) Tromethamin-salz von 1-methyl-beta-oxo-alpha(phenylcarbamoyl)-2-pyrrol-propionitril
DE69509621T2 (de) Diarylheptanoidderivat und diese enthaltende pharmazeutische Zusammensetzung
DE10356409B4 (de) Neues Arzneimittel Oxachelin und Derivate
CH639363A5 (de) Bis/nitrosoureido/-polyol-derivate und verfahren zu ihrer herstellung.
EP0313935A2 (de) Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE4003054A1 (de) Verwendung von benzylphosphonsaeurederivaten zur behandlung von durch viren verursachte krankheiten
EP0008073A1 (de) Thiosubstituierte Diazacycloalkene, Verfahren zu ihrer Herstellung und pharmazeutische Präparate
DE2440596C3 (de) N-P-N'-CyclohexyW'-Meftyl-N'-methylenAe,dibrom-phenylj -3-alkoxy- 4-acyloxy-benzamidhydrochlorid-Derivate, deren Herstellung und Verwendung
EP0049538A2 (de) Verwendung von Thioharnstoffderivaten als Arzneimittel bei der Behandlung von Fettstoffwechselstörungen
EP0105393B1 (de) Neue Nucleosidverbindungen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
EP0163905B1 (de) Racemische und optisch aktive 7-Oxo-prostacyclin-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DE2753768A1 (de) Antiphologistisch wirkende arzneimittel
DE2858177C2 (de) Arzneimittel enthaltend N-substituierte 2-Cyanaziridine

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 2858177

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 2858177

AH Division in

Ref country code: DE

Ref document number: 2858177

Format of ref document f/p: P

AH Division in

Ref country code: DE

Ref document number: 2858177

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee